Leading New York-based construction company Tishman Speyer has announced that it is set to begin constructing The Spiral in Manhattan, having both secured a $1.8bn loan from Blackstone Mortgage Trust, and finalized an 800,000 square foot lease with Pfizer.
Costing $3.7bn to build, with the further $1.9bn financing coming from Tishman Speyer equity, The Spiral will become the new headquarters of American pharmaceutical conglomerate Pfizer, with the company set to occupy 15 floors of the new building.
